Inari Medical, Inc. (NARI) Appoints Robert Warner to its Board

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the appointment of Mr. Robert Warner to its board of directors. Mr. Warner will serve as a member of the Audit Committee of the board.

“We are pleased to welcome Robert as a new independent director to our board. Mr. Warner’s decades of executive operating experience, including internationally, will be highly valuable to Inari as we enter the next phase of our mission to treat and transform the lives of patients suffering from venous and other diseases,” said Bill Hoffman, Inari’s Chief Executive Officer.

You May Also Be Interested In

• FDA approves Novartis Pluvicto for earlier-stage prostate cancer
• Coincheck Group N.V. (CNCK) files for 56.5M share offering by selling stockholders
• Quince Therapeutics (QNCX) files for 15.47M share offering by selling stockholders